These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

776 related articles for article (PubMed ID: 19752085)

  • 1. Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission.
    Hirsch HA; Iliopoulos D; Tsichlis PN; Struhl K
    Cancer Res; 2009 Oct; 69(19):7507-11. PubMed ID: 19752085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.
    Hirsch HA; Iliopoulos D; Struhl K
    Proc Natl Acad Sci U S A; 2013 Jan; 110(3):972-7. PubMed ID: 23277563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types.
    Iliopoulos D; Hirsch HA; Struhl K
    Cancer Res; 2011 May; 71(9):3196-201. PubMed ID: 21415163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo.
    Jia D; Tan Y; Liu H; Ooi S; Li L; Wright K; Bennett S; Addison CL; Wang L
    Oncotarget; 2016 Jan; 7(1):771-85. PubMed ID: 26506421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antitumor activity of doxorubicin by naringenin and metformin in breast carcinoma: an experimental study.
    Pateliya B; Burade V; Goswami S
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Sep; 394(9):1949-1961. PubMed ID: 34125254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinational strategies of metformin and chemotherapy in cancers.
    Zhang HH; Guo XL
    Cancer Chemother Pharmacol; 2016 Jul; 78(1):13-26. PubMed ID: 27118574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
    Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
    J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.
    Yu Z; Zhao G; Xie G; Zhao L; Chen Y; Yu H; Zhang Z; Li C; Li Y
    Oncotarget; 2015 Oct; 6(32):32930-43. PubMed ID: 26431379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells.
    Wang Y; Wei J; Li L; Fan C; Sun Y
    Oncol Res; 2014; 22(4):193-201. PubMed ID: 26351208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem/progenitor cell active compound 8-quinolinol in combination with paclitaxel achieves an improved cure of breast cancer in the mouse model.
    Zhou J; Zhang H; Gu P; Margolick JB; Yin D; Zhang Y
    Breast Cancer Res Treat; 2009 May; 115(2):269-77. PubMed ID: 18506619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced anti-tumor activity and cytotoxic effect on cancer stem cell population of metformin-butyrate compared with metformin HCl in breast cancer.
    Lee KM; Lee M; Lee J; Kim SW; Moon HG; Noh DY; Han W
    Oncotarget; 2016 Jun; 7(25):38500-38512. PubMed ID: 27223262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reprogramming ovarian and breast cancer cells into non-cancerous cells by low-dose metformin or SN-38 through FOXO3 activation.
    Hu T; Chung YM; Guan M; Ma M; Ma J; Berek JS; Hu MC
    Sci Rep; 2014 Jul; 4():5810. PubMed ID: 25056111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
    Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
    Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NF-kappaB pathway inhibitors preferentially inhibit breast cancer stem-like cells.
    Zhou J; Zhang H; Gu P; Bai J; Margolick JB; Zhang Y
    Breast Cancer Res Treat; 2008 Oct; 111(3):419-27. PubMed ID: 17965935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in [18F]Fluoro-2-deoxy-D-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling.
    Cooper AC; Fleming IN; Phyu SM; Smith TA
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1523-32. PubMed ID: 25579456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential target associated with both cancer and cancer stem cells: a combination therapy for eradication of breast cancer using vinorelbine stealthy liposomes plus parthenolide stealthy liposomes.
    Liu Y; Lu WL; Guo J; Du J; Li T; Wu JW; Wang GL; Wang JC; Zhang X; Zhang Q
    J Control Release; 2008 Jul; 129(1):18-25. PubMed ID: 18466993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Priori Activation of Apoptosis Pathways of Tumor (AAAPT) technology: Development of targeted apoptosis initiators for cancer treatment.
    Pandurangi RS; Tomasetti M; Verapazham ST; Paulmurugan R; Ma C; Rajput S; Anjanappa M; Nakshatri H
    PLoS One; 2021; 16(2):e0225869. PubMed ID: 33556062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination.
    Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN
    Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.